PTEN Loss Promotes PI3Kβ Phosphorylation and EPHA2/SRC/p-PI3KβY962 Complex Assembly to Drive Tumorigenesis

We revealed a critical new mechanism that PTEN loss induces PI3Kβ phosphorylation and EPHA2/SRC/p-PI3KβY962 complex signaling to drive tumorigenesis. This work directs pharmaceutical development of p-PI3KβY962 inhibitors and biomarker-driven clinical trials repurposing dasatinib for PTEN-deficient solid tumor treatment, with potential to significantly improve outcomes of broad patients with PTEN-deficient tumors.

Authors

Institutions

Publication Details

Journal
Cancer Discovery
Published
2025-11-14
DOI
https://doi.org/10.1158/2159-8290.cd-25-1126
Citations
1
Primary Topic
PI3K/AKT/mTOR signaling in cancer
Type
article
Field-Weighted Citation Impact
0.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PTEN Loss Promotes PI3Kβ Phosphorylation and EPHA2/SRC/p-PI3KβY962 Complex Assembly to Drive Tumorigenesis

Yutong Li, Shuang Tang, Da‐Qiang Li, Tao Jiang et al.
1 citations
Cancer Discovery
PI3K/AKT/mTOR signaling in cancer
0.81
article

PTEN Loss Promotes PI3Kβ Phosphorylation and EPHA2/SRC/p-PI3KβY962 Complex Assembly to Drive Tumorigenesis

Yutong Li, Shuang Tang, Da‐Qiang Li, Tao Jiang, X. Steven Wan, Thomas M. Roberts, Jean J. Zhao, Renlei Ji, Jared L. Johnson, Lewis C. Cantley, Tomer M. Yaron, Johann S. Bergholz, Bo Dai, Xiaoling Li, Zefeng Wang, Xiadi He, Wendi Huang, Jiachen Wu, Qian Zhou, Meng-Hong Sun, Qianchen Jing, Weihua Wang
article en
1 citations

Abstract

We revealed a critical new mechanism that PTEN loss induces PI3Kβ phosphorylation and EPHA2/SRC/p-PI3KβY962 complex signaling to drive tumorigenesis. This work directs pharmaceutical development of p-PI3KβY962 inhibitors and biomarker-driven clinical trials repurposing dasatinib for PTEN-deficient solid tumor treatment, with potential to significantly improve outcomes of broad patients with PTEN-deficient tumors.

Cancer DiscoveryVol. 16(3)
Shanghai Medical College of Fudan University (CN), Harvard University (US), Cornell University (US), Fudan University (CN), Inner Mongolia University (CN), Southern University of Science and Technology (CN), Lander Institute (IL), Triangle (US), Fudan University Shanghai Cancer Center (CN), National Institute of Environmental Health Sciences (US), Shanghai Institute of Nutrition and Health (CN), Dana-Farber Cancer Institute (US), Center for Excellence in Molecular Cell Science (CN), Harvard Stem Cell Institute (US), Columbia University (US)
Openalex Percentile: Top 22%
PI3K/AKT/mTOR signaling in cancer
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.